|
Jun 09, 2020
|
Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis
|
|
|
May 28, 2020
|
Dynavax to Present at the William Blair 40th Annual Growth Stock Conference
|
|
|
May 27, 2020
|
Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
|
|
May 21, 2020
|
Dynavax Technologies Announces Pricing of $70.0 Million Public Offering of Common Stock
|
|
|
May 21, 2020
|
Dynavax Technologies Announces Proposed Public Offering of Common Stock
|
|
|
May 07, 2020
|
Dynavax Announces First Quarter 2020 Financial Results
|
|
|
Apr 28, 2020
|
Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis
|
|
|
Apr 23, 2020
|
Dynavax to Report First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020
|
|
|
Apr 22, 2020
|
Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19
|
|
|
Apr 16, 2020
|
Dynavax and Sinovac Announce Collaboration to Develop a Coronavirus (COVID-19) Vaccine
|
|
